Finotive Funding May Madness Extension: Get it Now!

Finotive Funding has announced an extension of its highly popular May Madness promotion. Doubling down on the excitement, the firm has unveiled an array of exclusive prizes for lucky traders, making this opportunity even more enticing.

Finotive Funding May Madness Extension

The expanded prize pool now includes:

• Two lucky winners of 2x F1 tickets: These fortunate individuals will experience the thrill of the Monaco F1 Grand Prix from the unparalleled vantage point of a Superyacht alongside the esteemed CEO and COO of Finotive Funding.
• One winner of a 100k pro 2-step account
• One winner of a 50k pro 2-step account
• One winner of a 25k pro 2-step account

Additionally, Finotive Funding is offering a generous 20% discount on any account purchased until midnight Sunday. Traders looking to seize this opportunity can utilize the discount code “F1NEXT” to avail themselves of the discount while also entering the draw for the prestigious awards.

This promotion not only presents an exceptional chance to enhance one’s trading capabilities with top-tier accounts but also offers the allure of a luxurious trip to Monaco in grand style.

Also, this is your opportunity to join the elite at Finotive Funding—indulge in unmatched luxury and elevate your trading experience.

Traders should not miss their last chance to capitalize on this fantastic discount and potentially embark on an unforgettable journey to Monaco as part of the Finotive Funding family.

About the Firm

Finotive Funding encourages traders to thrive in their careers. The primary expectation from clients is that they are disciplined individuals proficient in effective risk management. Traders have the opportunity to earn substantial profits, with the flexibility to manage account sizes up to $200,000 and receive up to 100% profit splits. This can be accomplished through trading various financial instruments, including forex pairs, commodities, indices, and cryptocurrencies.

Also, don’t forget to read the Review.